Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

FATE

Fate Therapeutics Inc

May 22 • 04:00PM ET

2.25

+0.15 7.14 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: NKTX ALLO LYEL SANA PGEN

| Held by: IWM VTI IWN VXF SCHA VTWO PRFZ IWC VHT QQQS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.09	Insider Own	4.72%	Shs Outstand	116.27M	Perf Week	28.21%
Market Cap	262.26M	Forward P/E	-	EPS next Y	-0.97	Insider Trans	-1.26%	Shs Float	111.05M	Perf Month	70.45%
Enterprise Value	164.22M	PEG	-	EPS next Q	-0.27	Inst Own	68.10%	Short Float	9.23%	Perf Quarter	49.01%
Income	-129.91M	P/S	41.50	EPS this Y	5.77%	Inst Trans	10.19%	Short Ratio	4.63	Perf Half Y	114.29%
Sales	6.32M	P/B	1.46	EPS next Y	10.30%	ROA	-38.01%	Short Interest	10.26M	Perf YTD	128.98%
Book/sh	1.55	P/C	1.50	EPS next 5Y	5.01%	ROE	-55.50%	52W High	2.46 -8.72%	Perf Year	87.50%
Cash/sh	1.50	P/FCF	-	EPS past 3/5Y	26.67% 11.42%	ROIC	-51.60%	52W Low	0.91 147.25%	Perf 3Y	-56.98%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-58.98% -26.71%	Gross Margin	-97.69%	Volatility	13.58% 12.93%	Perf 5Y	-96.95%
Dividend TTM	-	EV/Sales	25.98	EPS Y/Y TTM	26.97%	Oper. Margin	-2207.47%	ATR (14)	0.22	Perf 10Y	49.01%
Dividend Ex-Date	-	Quick Ratio	5.85	Sales Y/Y TTM	-52.64%	Profit Margin	-2056.79%	RSI (14)	63.87	Recom	1.91
Dividend Gr. 3/5Y	- -	Current Ratio	5.85	EPS Q/Q	18.19%	SMA20	18.64%	Beta	2.25	Target Price	5.41
Payout	-	Debt/Eq	0.43	Sales Q/Q	-20.26%	SMA50	50.38%	Rel Volume	2.66	Prev Close	2.10
Employees	161	LT Debt/Eq	0.40	Earnings	May 13 BMO	SMA200	79.86%	Avg Volume	2.22M	Price	2.25
IPO	Oct 01, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	7.14% -12.93%	Trades		Volume	5,901,229	Change	7.14%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)